HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Straighten the cleaning solution Pour it into the cleaning position for cleaning Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes,ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
Saline Solution is intended for use in OTC ear,nose,and throat devices intended specifically to administer medicinal substances to treat ear,nose,and throat disorders.These instruments include the powder blower,dropper,ear wick,manual nebulizer pump,and nasal inhaler. If using with an OTC ear,nose,or throat device,the follow the directions provided with the device and only use as directed.
HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes, ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. The pH ranges from 4.5 to 7.0. Composition, osmolarity, and ionic concentration are shown below: 0.9% Sodium Chloride Injection, USP contains 9 g/L Sodium Chloride, USP (NaCl) with an osmolarity of 308 mOsmol/L (calc). It contains 154 mEq/L sodium and 154 mEq/L chloride. The FLEBOFLEX and FLEBOFLEX LUER plastic containers are fabricated from latex-free polyolefins or polypropylene plastic materials. The solution contact materials do not contain PVC, DEHP, or other plasticizers. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. The suitability of the container materials has been established through biological evaluations, which have shown the containers pass Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container systems.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
0.9% Sodium Chloride Injection, USP solution is sterile and nonpyrogenic. It is a parenteral solution containing sodium chloride in water for injection intended for intravenous administration. For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1,000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solution is a parenteral fluid and electrolyte replenisher. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for injection, USP is chemically designated H2O. The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (freeflex® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. 0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution of sodium chloride and water for injection. Each mL contains sodium chloride 9 mg. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. 0.308 mOsmol/mL (calc.). 0.9% Sodium Chloride Injection, USP contains no preservatives. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. pH 5.3 (4.5 to 7.0). Sodium Chloride, USP is chemically designated NaCl, a white crystalline compound freely soluble in water. The glass container is a Type I borosilicate glass and meets the requirements of the powdered glass test according to the USP standards. The semi-rigid vial is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper drug concentration.
12 CELL SALTS COMPLEXCALCAREA FLUORICA CALCAREA PHOSPHORICA CALCAREA SULPHURICA FERRUM PHOSPHORICUM KALI MURIATICUM KALI PHOSPHORICUM KALI SULPHURICUM MAGNESIA PHOSPHORICA NATRUM MURIATICUM NATRUM PHOSPHORICUM NATRUM SULPHURICUM SILICEA
INDICATIONS: For weight management and inflammation support. This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
3% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. The pH may have been adjusted with hydrochloric acid. It contains no antimicrobial agents. Composition, ionic concentration, osmolarity, and pH are shown in Table 1 . Table 1. *Normal physiological osmolarity range is approximately 280 to 310 mOsmol/L. Size (mL) Composition (g/L) Ionic Concentration (mEq/L) *Osmolarity (mOsmol/L) (calc) pH Sodium Chloride, USP (NaCl) Sodium Chloride 3% Sodium Chloride Injection, USP 500 30 513 513 1,027 5.0 (4.5 to 7.0) The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (free flex ® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
4 Kids Cold and Cough DaytimeONION CALCIUM SULFIDE SODIUM CHLORIDE PHOSPHORUS PULSATILLA VULGARIS SULFUR AND GOLDENSEAL
Uses* ■ Helps temporarily relieve symptoms of common cold in children at night, including: ■ cough ■ runny nose ■ post nasal drip ■ sneezing ■ sore throat ■ nasal or chest congestion ■ occasional sleeplessness
Uses ■ Helps temporarily relieve symptoms of common cold in children at night, including: ■ cough ■ runny nose ■ post nasal drip ■ sneezing ■ sore throat ■ nasal or chest congestion ■ occasional sleeplessness
4 Kids Cold and Mucus NighttimeEUPHRASIA STRICTASILICON DIOXIDE RUMEX CRISPUS ROOT ANEMONE PULSATILLA GOLDENSEAL SODIUM CHLORIDE PHOSPHORUS ONION BRYONIA ALBA ROOT MATRICARIA CHAMOMILLA ARABICA COFFEE BEAN CALCIUM SULFIDE AND SULFUR
Uses Temporarily relieves the symptoms of the common cold in children especially at night including accumulation of mucus in chest, throat and nose, cough with mucus, runny nose, sneezing, nasal congestion and occasional sleeplessness.
4 KIDS COLD N COUGH GRAPE FLAVORONION CALCIUM SULFIDE GOLDENSEAL SODIUM CHLORIDE PHOSPHORUS ANEMONE PULSATILLA AND SULFUR
Uses ■Temporarily relieves symptoms of common cold in children, including: ■ accumulation of mucus in chest, throat or nose ■ cough with expectoration of thick, discolored mucus ■ runny nose ■ sneezing ■ nasal or chest congestion
911 Adrenal Burnout and FatigueACETICUM AC ADRENALINUM ADRENOCORTICOTROPHIN 30X AESCULUS HIPPOCASTANUM FLOS ALFALFA ALPHA LIPOIC AC AMBRA ARG NIT AVENA SATIVA BRYONIA CARBONEUM OXYGENISATUM CARPINUS BETULUS FLOS DNA FUMARICUM ACIDUM GELSEMIUM SEMPERVIRENS HEPAR SULPHURIS CALCAREUM HYPOTHALAMUS KALI PHOSPHORICUM LACTICUM ACIDUM LECITHIN NATRUM MURIATICUM OXALICUM ACIDUM PHOSPHORICUM ACIDUM PITUITARUM POSTERIUM SARCOLACTICUM ACIDUM SELENIUM METALLICUM SEPIA SILICEA SUCCINICUM ACIDUM AND THYROIDINUM.
Uses † for temporary relief of: physical fatigue mental and emotional fatigue nervous exhaustion sluggish mind poor concentration weariness confusion apathy irritability indifference body aches lack of focus eyes sensitive to light digestive symptoms caused by stress light-headed upon standing up † Claims based on traditional Homeopathic practice, not accepted medical evidence, not FDA evaluated.
INDICATIONS: For temporary relief of allergies due to grains and seeds.** **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
Sprayology PMS Support Apis mellifica, Chamomilla, Cimicifuga racemosa, Cuprum metallicum, Ignatia amara, Kali iodatum, Magnesia phosphorica, Oophorinum, Platinum metallicum, Sepia, Thuja occidentalis APIS MELLIFERA APIS MELLIFERA MATRICARIA RECUTITA MATRICARIA RECUTITA BLACK COHOSH BLACK COHOSH COPPER COPPER STRYCHNOS IGNATII SEED STRYCHNOS IGNATII SEED POTASSIUM IODIDE IODIDE ION MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE MAGNESIUM CATION SUS SCROFA OVARY SUS SCROFA OVARY PLATINUM PLATINUM SEPIA OFFICINALIS JUICE SEPIA OFFICINALIS JUICE THUJA OCCIDENTALIS LEAFY TWIG THUJA OCCIDENTALIS LEAFY TWIG GLYCERIN ALCOHOL WATER
INDICATIONS: For temporary relief of symptoms related to heavy metal toxicity including gastritis, cough, poor concentration, nausea, vomiting, diarrhea, stomach pain, sweating, and a metallic taste in the mouth.
INDICATIONS FOR USE: For the temporary relief of symptoms such as: • pain • burning • weakness • sensitivity • tingling • numbness Product indications are based solely on Homeopathic Materia Medica and have not been evaluated by the FDA.
INDICATIONS: Spleen, Pancreas, Stomach support.** **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
Indications: For temporary relief of marked debility producing nervous exhaustion, weakness and exhaustion following acute illness and rheumatic pains in the sacrum and joints with muscular weakness.
Arthritis/Joints Gnaphalium Polycephalum, Berberis Vulgaris, Cimicifuga Racemosa, Cinchona Officinalis, Colocynthis, Ledum Palustre, Ranunculus Bulbosus, Aesculus Hippocastanum, Borax, Cuprum Aceticum, Kali Carbonicum, Pulsatilla (Vulgaris), Secale Cornutum, Ammonium Muriaticum, Silicea, Argentum Metallicum, Calcarea Phosphorica, Glandula Suprarenalis Suis, Mercurius Praecipitatus Ruber, Sepia, Zincum Metallicum, Palladium Metallicum, Picricum Acidum, Sulphur, Cartilago Suis, Discus Intervertebralis Suis, Medulla Ossis Suis PSEUDOGNAPHALIUM OBTUSIFOLIUM PSEUDOGNAPHALIUM OBTUSIFOLIUM BERBERIS VULGARIS ROOT BARK BERBERIS VULGARIS ROOT BARK BLACK COHOSH BLACK COHOSH CINCHONA OFFICINALIS BARK CINCHONA OFFICINALIS BARK CITRULLUS COLOCYNTHIS FRUIT PULP CITRULLUS COLOCYNTHIS FRUIT PULP LEDUM PALUSTRE TWIG LEDUM PALUSTRE TWIG RANUNCULUS BULBOSUS RANUNCULUS BULBOSUS HORSE CHESTNUT HORSE CHESTNUT SODIUM BORATE BORATE ION CUPRIC ACETATE CUPRIC CATION POTASSIUM CARBONATE CARBONATE ION PULSATILLA VULGARIS ANEMONE PULSATILLA CLAVICEPS PURPUREA SCLEROTIUM CLAVICEPS PURPUREA SCLEROTIUM AMMONIUM CHLORIDE AMMONIUM CATION SILICON DIOXIDE SILICON DIOXIDE SILVER SILVER TRIBASIC CALCIUM PHOSPHATE CALCIUM CATION SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND MERCURIC OXIDE MERCURIC OXIDE SEPIA OFFICINALIS JUICE SEPIA OFFICINALIS JUICE ZINC ZINC PALLADIUM PALLADIUM PICRIC ACID PICRIC ACID SULFUR SULFUR SUS SCROFA CARTILAGE SUS SCROFA CARTILAGE SUS SCROFA INTERVERTEBRAL DISC SUS SCROFA INTERVERTEBRAL DISC SUS SCROFA BONE MARROW SUS SCROFA BONE MARROW WATER ALCOHOL
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to arthritis, including rash, itching, tingling, stress headache, fatigue, swelling and joint pain.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
INDICATIONS & USAGE SECTION Vitiligo Formulated for symptoms associated with pigmentation loss, changes in the skin, inflammation, itching and premature graying.
HOMEOPATHIC INDICATIONS: For the temporary relief of symptoms of Herpes Simplex such as painful eruptions of lips, genitals, vesicular/blister of lips and genitals, tingling of lips, fatigue, irritability, fever, body aches and burning during urination.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to heavy metal toxicity including cough, poor concentration, nausea, vomiting, occasional diarrhea, stomach pain, headache, sweating, and a metallic taste in the mouth.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to heavy metal toxicity including cough, poor concentration, nausea, vomiting, occasional diarrhea, stomach pain, headache, sweating, and a metallic taste in the mouth.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.
INDICATIONS: For temporary relief of sinus congestion, dry cough in the evening and rhinitis.** **These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
HOMEOPATHIC INDICATIONS: For the temporary relief of symptoms of stress such as terror, horror, post traumatic stress, fight or flight response, recurring nightmares, difficulty sleeping, difficulty concentrating, restlessness, and easy irritability.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.